Trial Profile
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Effect of Bosentan in Patients With Stage IV Metastatic Melanoma Treated With Dacarbazine.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary) ; Dacarbazine
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Actelion Pharmaceuticals
- 14 Nov 2009 New trial record